Dr Matthew Grayson

Natural Sciences (Physical and Biological)

Research Themes

The prevalence of chiral therapeutic compounds in the pharmaceutical sector is higher than ever before. Of the twenty top-selling prescription pharmaceuticals globally in 2012, twelve were chiral organic drug molecules. As a consequence of this global need for chiral molecules, asymmetric reactions are required.

My research utilises both computational and experimental techniques to gain an insight into asymmetric catalytic transformations. The knowledge gained from this work is applied to the rational design of new reactions which are then used in the development of novel therapeutic agents.

College Role

Research Fellow

Degrees, Awards and Prizes

MSci, MA, PhD (Cantab).
Organic & Biomolecular Chemistry Prize (2013).
Alex Hopkins Prize (2010).
Katritzky Prize (2009).